The Korean drug approval process ensures that multinational companies meet local safety, efficacy, and quality standards before marketing their drugs in South Korea. Companies must submit clinical trial data, comply with regulatory requirements, and gain approval from agencies like the Ministry of Food and Drug Safety (MFDS) to enter the Korean pharmaceutical market.